# Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

> **NCT00701259** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 852 (actual)

## Conditions studied

- Frequent Heartburn

## Interventions

- **DRUG:** Lansoprazole
- **DRUG:** Lansoprazole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00701259
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 852 (ACTUAL)
- **Last updated:** 2010-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701259, "Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00701259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*